Back to search

National and Kapodistrian University of Athens

Μοριακή μελέτη για την ανακάλυψη βιοδεικτών και θεραπευτικών στόχων στον καρκίνο της ουροδόχου κύστης

Abstract

dc:description

Diagnosis, treatment and follow-up of bladder cancer is a complex global health problem. The role of cytology in the diagnosis and monitoring of bladder cancer is crucial. The revised Paris System for Reporting Urinary Cytology (TPS) presented clearly defined morphologic criteria, emphasizing in the most clinically relevant diagnosis of high-grade urothelial carcinoma, reducing uncertain diagnoses. In our study, we evaluated the risk of malignancy (ROM) for each TPS category by studying prospectively 110 patients who underwent transurethral removal of bladder tumor in our clinic. The diagnostic accuracy of urine cytology proved to be very high for the diagnosis of high-grade urothelial carcinoma, supporting the fundamental role of cytology in urinary oncology. In an effort to enhance the ability to predict bladder cancer recurrence, we compiled a discovery meta-cohort of 1135 bladder cancer microarray transcriptomes and addressed the disease as a molecular continuum of alterations. Using the stage as a checkpoint variable that reflects the cumulative processes of tumor progression, we investigated how molecular processes and gene expression levels change. Based on the hypothesis that the expression levels of the most optimal prognostic biomarkers should follow a monotonal trend with higher disease stage, we propose an eight-gene signature, capable of stratifying patients into low- and high-risk for bladder cancer recurrence probability. Finally, by selecting one of the 8 genes of the gene signature, ZFP2, which is the less studied in the literature, we created a preliminary cohort of 14patients who underwent transurethral removal of bladder tumor in 1st Urology Department of the University of Athens. In these samples we measured ZFP2 gene expression by PT-PCR analysis. Data analysis confirmed our observations and showed that ZFP2 gene expression levels are upregulated in those patients who remain relapse-free. Further validation of the use of ZFP2 in clinical trials is required before clinical implementation in the follow-up of bladder cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Moulavasilis, Napoleon
  • Μουλαβασίλης, Ναπολέων

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55492

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Moulavasilis, Napoleon; Μουλαβασίλης, Ναπολέων. Μοριακή μελέτη για την ανακάλυψη βιοδεικτών και θεραπευτικών στόχων στον καρκίνο της ουροδόχου κύστης. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/55492